Name: 글로벌 신속 구강액 검사 기기 시장 - 2022-2029 - 프라임리서치
SKU: DMMD1445
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 신속 구강액 검사 기기 시장 규모는 2021년 XX백만 달러였으며, 2029년까지 XX백만 달러에 도달할 것으로 예상되며, 예측 기간(2022-2029년) 동안 연평균 성장률(CAGR)은 XX%입니다.
구강액 검사는 비침습적이고 직접 관찰 가능한 검체 채취 방법으로 점점 더 인기를 얻고 있습니다. 구강액 검사는 소변 검사보다 검출 기간이 짧고 혈중 약물 농도와의 상관관계가 높아 약물 남용 여부를 더 잘 나타내는 지표입니다.
시장 동향
전 세계 신속 구강액 검사 기기 시장은 구강 질환 유병률 증가, 기술 발전, 의료 기기 연구 개발, 첨단 의료 기술 도입, 신속 약물 검사에 대한 환자 인식 향상, 의료비 지출 증가에 힘입어 성장하고 있습니다.
약물 남용 및 알코올 중독 사례 증가가 시장 성장을 견인합니다.
젊은 성인층의 약물 및 알코올 중독 검사 수요 증가가 예측 기간 동안 시장 성장을 주도할 것으로 예상됩니다. 2022년 Scientific Reports에 발표된 논문에 따르면, 젊은 성인들은 바, 클럽, 축제와 같은 다양한 나이트라이프 장소를 자주 방문하고 어울립니다. 연구에 따르면 이러한 환경에서 향정신성 물질 사용률이 특히 높습니다. 불법 약물 사용은 과도한 알코올 섭취와 관련이 있다는 연구 결과도 있습니다. 알코올과 불법 약물의 사용은 폭력(성폭행 포함), 사고, 심지어 사망과 같은 심각한 결과를 초래할 수 있습니다. 이러한 물질을 자주 사용하면 물질 사용 장애를 포함한 신체적, 정신적 질병의 위험이 증가합니다.
또한, 호주 클럽 방문객을 대상으로 구강액 샘플을 이용한 현장 면역학적 신속 선별 검사를 실시한 결과, 9%가 약물 사용을 보고했고 20%가 양성 반응을 보였습니다. 구강액 샘플링은 혈액 샘플링과 유사한 비침습적 방법이지만, 일부 참가자의 경우 구강 건조로 인해 샘플링에 시간이 오래 걸릴 수 있습니다.

구강액 검사의 이점과 활용에 대한 인식과 이해 부족은 시장 성장을 저해할 수 있습니다.
그러나 여러 요인이 신속 구강액 검사 기기 시장의 성장을 제약할 수 있습니다. 여기에는 구강액 검사의 이점과 활용에 대한 인식과 이해 부족이 포함될 수 있습니다. 구강액 검사는 비교적 새롭고 발전하는 분야이므로 많은 사람들이 이에 대해 더 잘 알거나 잠재적인 적용 분야에 대해 인지할 필요가 있습니다. 결과적으로, 구강액 검사 기기를 사용하거나 구강액 검사 서비스를 찾는 데 소극적일 수 있습니다. 이는 특히 첨단 의료 기술에 대한 이해도가 낮거나 진단 검사 사용에 익숙하지 않은 계층에서 더욱 두드러질 수 있습니다.
하지만 구강액 검사에 대한 정보가 더 많이 제공되고 더 많은 사람들이 그 이점과 활용에 대해 알게 됨에 따라 신속 구강액 검사 기기에 대한 수요가 증가할 가능성이 높습니다. 이는 해당 기기 시장의 성장을 견인할 수 있습니다.

COVID-19 영향 분석
COVID-19의 출현은 전 세계 구강액 검사 기기 시장에 상당한 영향을 미쳤습니다. 2021년 임상미생학 저널(Journal of Clinical Microbiology)에 발표된 논문에 따르면, FDA에서 권장하는 검사 기준을 충족하면서 대량 생산이 가능한 비침습적 SARS-CoV-2 항체 검사의 필요성으로 인해 OraSure Technologies와의 협력이 이루어졌습니다. OraSure Technologies의 구강 검체 채취 장치(OSCD)는 이미 HIV-1에 대한 구강액 항체를 채취하고 보존하는 능력이 입증되었습니다. SARS-CoV-2 항체 채취 효율을 높이기 위해 개선된 이 구강 항체 채취 장치(OACD)는 염분과 구연산을 함유한 흡수 패드를 사용하여 잇몸과 볼 사이에서 구강액을 채취합니다. 구강 내 이 부위에는 항체가 풍부한 치은열구액이 존재합니다. 따라서 OACD는 이 부위에서 검체를 채취함으로써 타액만 채취했을 때보다 항체가 더 풍부한 구강액 검체를 얻을 수 있습니다.

부문 분석
질병 검사 부문은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
질병 검사 부문은 가장 큰 시장 점유율을 차지하고 있습니다. 코로나19 팬데믹 기간 동안 임상 및 의료 수요가 급증했습니다. 팬데믹 기간 동안 주요 과제로는 검사 키트 부족, 코로나19 중증 환자 치료를 위한 인공호흡기 부족, 병원 및 일반 대중을 위한 개인 보호 장비 부족 등이 있었습니다. 과학자, 연구원 및 기업들은 이러한 수요에 대응하여 신속 구강액 검사 장치를 포함한 새로운 기술을 개발했으며, 신속 구강액 검사를 통한 진단 수요 증가로 이어졌습니다.
또한, VerOFy와 LIAM의 신속 타액 현장 진단(Rapid Saliva Point-of-Care Testing)은 신속하고 표준화된 타액(구강액) 채취와 고품질 면역크로마토그래피 검사 스트립을 결합한 독자적인 플랫폼 기술을 VerOFy에 제공하여 현장 또는 진료 현장에서 즉각적인 결과를 제공합니다.

지리적 분석
북미 지역은 전 세계 구강액 신속 검사 기기 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 구강액 신속 검사 기기 시장을 주도하고 있으며, 예측 기간 동안에도 이러한 추세가 지속될 것으로 예상됩니다. 북미 지역이 전 세계 구강액 신속 검사 기기를 주도하는 데에는 여러 가지 이유가 있습니다. 이 지역의 탄탄한 의료 인프라와 선진 의료 기술은 구강액 검사 기기의 높은 보급률에 기여했습니다. 또한, 약물 남용 및 중독률이 높은 이 지역은 신뢰할 수 있고 정확한 검사 방법에 대한 강력한 수요를 창출했습니다. 북미 시장에서 다양한 구강액 신속 검사 기기를 이용할 수 있다는 점, 그리고 구강액 검사 기기의 승인 및 판매에 유리한 규제 환경이 조성되어 있다는 점도 중요한 요인입니다. 북미 지역의 높은 의료비 지출 또한 구강액 신속 검사 기기 시장의 성장을 촉진하는 데 기여했습니다.

또한, OraSure Technologies는 특허받은 특수 처리 패드를 사용하여 평균 3분 만에 검체를 채취할 수 있고, 사전 채취 샘플 혼합이 필요 없으며, 인체공학적으로 설계된 편안한 사용자 경험을 제공하는 Intercept i2 구강액 채취 장치를 제공합니다.
경쟁 환경
신속 구강액 검사 장치 시장은 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. 시장 성장에 기여하는 주요 기업으로는 OraSure Technologies, Inc., Abbott Laboratories, Guangzhou Wondfo Biotech Co., Ltd., Oranoxis Inc., Premier Biotech, Inc., UCP Biosciences, Inc., SCREEN ITALIA SRL, Securetec Detektions-Systeme AG, MEDACX Ltd., AccuBioTech Co. Ltd. 등이 있습니다. 주요 기업들은 신제품 출시, 인수, 협력 등 다양한 성장 전략을 통해 전 세계 신속 구강액 검사 장치 시장의 성장에 기여하고 있습니다.

예를 들어,
• 2020년 4월, 현장 진단 검사, 검체 채취 기기, 마이크로바이옴 실험실 및 분석 서비스 분야의 선도 기업인 오라슈어 테크놀로지스(OraSure Technologies, Inc.)는 미국 보건복지부(HHS) 산하 생물의학첨단연구개발국(BARDA)으로부터 구강액 검체를 사용하는 범 SARS 코로나바이러스 항원 신속 자가 진단 키트 개발을 위한 710,310달러 규모의 계약을 수주했습니다. BARDA의 지원을 통해 오라슈어는 미국 식품의약국(FDA)의 긴급사용승인(EUA)을 신청하여 미국 시장에 자가 진단 키트를 출시할 수 있게 되었습니다.

애보트 연구소(Abbott Laboratories)
개요:
애보트 연구소는 1888년에 설립되어 미국에 본사를 둔 헬스케어 및 의료기기 기업입니다. 130년이 넘는 세월 동안 애보트는 과학과 혁신을 바탕으로 건강의 힘을 통해 더 많은 사람들에게 더 많은 기회를 제공하기 위해 노력해 왔습니다.

제품 포트폴리오:
OrALert 구강액 약물 검사 장치: OrALert 구강액 약물 검사 장치는 간편하고 신속하며 10분 이내에 결과를 제공합니다. 장점으로는 mAMP OPI, AMP, BZO, COC, PCP 및 THC1을 포함한 다양한 검사 가능, 모체 THC 검출률 향상, 타액 내 불법 약물 및 처방약에 대한 신뢰할 수 있는 검사, 검체 노출 최소화, 분할 검체 웰 등이 있습니다.
글로벌 신속 구강액 약물 검사 장치 시장 보고서는 약 60개 이상의 시장 데이터 표, 60개 이상의 그림, 그리고 약 200페이지 분량으로 구성되어 있습니다.

보고서 요약(영어 원문)

Market Overview
The global rapid oral fluid screening device market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).
Oral fluid screening is increasingly popular as it is a non-invasive and directly observable sample collection method. Oral fluid screening is a better indicator of impairment as it has a shorter detection window and a stronger correlation with blood drug concentrations than urine testing.
Market Dynamics
The global rapid oral fluid screening device market is driven by the rising prevalence of oral disorders, technological advancements, research and development in medical devices, adoption of advanced healthcare technologies, improving patient awareness about rapid drug screening, and rising healthcare expenditure.
Increasing cases of drug abuse and alcoholism drives market growth
The rising demand for testing drugs and alcoholism in young adults drive the market in the forecast period. As per the article published in Scientific Reports in 2022, young adults frequently visit and socialize in different nightlife venues such as bars, clubs, and festivals. Studies have shown that psychoactive substance use is especially high in these environments. Research indicates that illicit drug use is associated with high levels of alcohol consumption. The use of alcohol and illicit drugs can lead to serious acute consequences such as violence (including sexual assault), accidents, and even death. Frequent use of these substances increases the risk of physical and mental illnesses, including substance use disorders.
In addition, an on-site immunological quick screening test of oral fluid samples has also been conducted among Australian clubgoers, demonstrating that 9% had reported drug use and 20% tested positive. Although oral fluid sampling is a non-invasive method, which agrees with the results obtained from blood sampling, sampling can be time-consuming in some participants, often due to a dry mouth, which some drugs or medications can induce.
Limited awareness and understanding about the benefits and uses of oral fluid testing will hamper the growth of the market
However, several factors could restrain the growth of the rapid oral fluid screening device market. These may include limited awareness and understanding of the benefits and uses of oral fluid testing. Limited awareness and understanding of the benefits and uses of oral fluid testing can be a factor that restrains the growth of the rapid oral fluid screening device market. Oral fluid testing is a relatively new and evolving field, and many people may need to be more familiar with it or aware of its potential applications. Resulting, they may be less likely to use oral fluid screening devices or seek out oral fluid testing services. This can be especially true in segments of the population that may need to become more familiar with advanced medical technologies or more accustomed to using diagnostic testing.
However, as more information about oral fluid testing becomes available and more people become aware of its benefits and uses, the demand for rapid oral fluid screening devices will likely increase. This could drive growth in the market for these devices.
COVID-19 Impact Analysis
The appearance of COVID-19 considerably impacted the global oral fluid screening device market. As per the article published in the Journal of Clinical Microbiology in 2021, the need for a noninvasive SARS-CoV-2 antibody test that could be mass-produced for widespread testing and maintain testing specifications recommended by the FDA led to a collaboration with OraSure Technologies. The ability of OraSure Technologies' oral specimen collection device (OSCD) to gather and preserve oral fluid antibodies against human immunodeficiency virus type 1 has previously been established (HIV-1). Their oral antibody collection device (OACD), modified for better antibody collection for antibodies against SARS-CoV-2, uses an absorbent pad containing salts and citric acid to collect oral fluid between the gums and cheeks. An antibody-rich gingival crevicular fluid is present in this area of the mouth. Therefore, by taking samples from this area, the OACD obtains oral fluid samples that are more abundant in antibodies than saliva alone.
Segment Analysis
The disease testing segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The disease testing segment accounts for the largest market share. During COVID-19, clinical and healthcare demands have been on the rapid rise. Major challenges during the pandemic have included a lack of testing kits, shortages of ventilators to treat severe cases of COVID-19, and insufficient access to personal protective equipment for hospitals and the public. Scientists, researchers, and companies have developed new technologies, including rapid oral fluid screening devices, in response to these demands—increasing demand for disease testing by using rapid oral fluid screening for diagnosis.
In addition, VerOFy & LIAM Rapid Saliva Point-of-Care Testing offers VerOFy a unique platform technology that combines rapid and standardized saliva [oral fluid] collection with high-quality immunochromatographic test strips for delivery of immediate results in the field or point-of-care locations.
Geographical Analysis
North America region holds the largest market share of the global rapid oral fluid screening device market
North America dominates the market for rapid oral fluid screening devices and is anticipated to show a similar trend over the forecast period. There are several reasons why the North American region may dominate the rapid oral fluid screening market globally. Strong healthcare infrastructure and advanced medical technologies in the region have contributed to the high adoption rate of oral fluid screening devices. The region's high prevalence of substance abuse and addiction has led to a strong demand for reliable and accurate testing methods. The availability of a wide range of rapid oral fluid screening devices in the North American market offers consumers various options—a favorable regulatory environment for the region's approval and marketing of oral fluid screening devices. High levels of healthcare spending in the North American region have helped fuel the growth of the rapid oral fluid screening market.
In addition, OraSure Technologies offers Intercept i2 Oral Fluid Collection Device that provides a 3-minute collection time (average) with a patented treated pad, no pre-collection sample pooling required, and an ergonomic collector designed for a comfortable end-user experience.
Competitive Landscape
The rapid oral fluid screening device market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are OraSure Technologies, Inc, Abbott Laboratories, Guangzhou Wondfo Biotech Co., Ltd, Oranoxis Inc, Premier Biotech, Inc, UCP Biosciences, Inc., SCREEN ITALIA SRL, Securetec Detektions-Systeme AG, MEDACX Ltd., and AccuBioTech Co. Ltd, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the rapid oral fluid screening device market globally.
For instance,
• In April 2020, OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, was awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS), to design a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples. This support from BARDA will enable OraSure to file for FDA Emergency Use Authorization (EUA), allowing an in-home self-test to debut in the U.S. market.
Abbott Laboratories
Overview:
Abbott Laboratories is a healthcare and medical device organization founded in 1888 and headquartered in the United States. For over 130 years, the company put science and innovation to work – to develop more opportunities for more people through the power of health.
Product Portfolio:
OrALert ORAL FLUID DRUG SCREEN DEVICE: The OrALert Oral Fluid Drug Screen Device is easy, quick, and provides results in under 10 minutes. Benefits include Available tests including mAMP OPI, AMP, BZO, COC, PCP and THC1, improved detection of parent THC, reliable screening for illicit and prescription drugs in saliva, minimum exposure to specimen, and split specimen well.
The global rapid oral fluid screening device market report would provide access to approximately 60+ market data tables, 60+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing cases of drug abuse and alcoholism
4.1.1.2. Tougher regulations and mandates for drug and alcohol testing
4.1.1.3. The growing emphasis on workplace screening among urban populations
4.1.2. Restraints:
4.1.2.1. Lack of awareness regarding the availability of advanced rapid saliva screening devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. 1- Panel Saliva Drug Test Kit*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. 4- Panel Saliva Drug Test Kits
7.4. 5- Panel Saliva Drug Test Kits
7.5. 6- Panel Saliva Drug Test Kits
7.6. 10- Panel Saliva Drug Test Kits
7.7. 12- Panel Saliva Drug Test Kits
8. By Form
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Cassettes*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Swabs
8.4. Strips
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Criminal Justice Testing*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Workplace Testing
9.4. Disease Testing
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Diagnostic Laboratories
10.4. Forensic Laboratories
10.5. Private Employers
10.6. Home Care Settings
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Type Benchmarking
13. Company Profiles
13.1. OraSure Technologies, Inc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Abbott Laboratories
13.3. Guangzhou Wondfo Biotech Co., Ltd
13.4. Oranoxis Inc
13.5. Premier Biotech, Inc
13.6. UCP Biosciences, Inc.
13.7. SCREEN ITALIA SRL
13.8. Securetec Detektions-Systeme AG
13.9. MEDACX Ltd.
13.10. AccuBioTech Co. Ltd
LIST NOT EXHAUSTIVE
14. Global Rapid Oral Fluid Screening Device Market – DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

언급된 주요 기업들

OraSure Technologies, Inc, Abbott Laboratories, Guangzhou Wondfo Biotech Co., Ltd, Oranoxis Inc, Premier Biotech, Inc, UCP Biosciences, Inc., SCREEN ITALIA SRL, Securetec Detektions-Systeme AG, MEDACX Ltd., AccuBioTech Co. Ltd

표 목록 (Tables)

List of Tables

Table 01 Global Rapid Oral Fluid Screening Device Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 02 Global Rapid Oral Fluid Screening Device Market Value, By Form, 2023, 2027 & 2031 ($ Million)

Table 03 Global Rapid Oral Fluid Screening Device Market Value, By Application, 2023, 2027 & 2031 ($ Million)

Table 04 Global Rapid Oral Fluid Screening Device Market Value, By End User, 2023, 2027 & 2031 ($ Million)

Table 05 Global Rapid Oral Fluid Screening Device Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 06 Global Rapid Oral Fluid Screening Device Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 07 Global Rapid Oral Fluid Screening Device Market Value, By Product Type, 2022-2031 ($ Million)

Table 08 Global Rapid Oral Fluid Screening Device Market Value, By Form, 2023, 2027 & 2031 ($ Million)

Table 09 Global Rapid Oral Fluid Screening Device Market Value, By Form, 2022-2031 ($ Million)

Table 10 Global Rapid Oral Fluid Screening Device Market Value, By Application, 2023, 2027 & 2031 ($ Million)

Table 11 Global Rapid Oral Fluid Screening Device Market Value, By Application, 2022-2031 ($ Million)

Table 12 Global Rapid Oral Fluid Screening Device Market Value, By End User, 2023, 2027 & 2031 ($ Million)

Table 13 Global Rapid Oral Fluid Screening Device Market Value, By End User, 2022-2031 ($ Million)

Table 14 Global Rapid Oral Fluid Screening Device Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 15 Global Rapid Oral Fluid Screening Device Market Value, By Region, 2022-2031 ($ Million)

Table 16 North America Rapid Oral Fluid Screening Device Market Value, By Product Type, 2022-2031 ($ Million)

Table 17 North America Rapid Oral Fluid Screening Device Market Value, By Form, 2022-2031 ($ Million)

Table 18 North America Rapid Oral Fluid Screening Device Market Value, By Application, 2022-2031 ($ Million)

Table 19 North America Rapid Oral Fluid Screening Device Market Value, By End User, 2022-2031 ($ Million)

Table 20 North America Rapid Oral Fluid Screening Device Market Value, By Country, 2022-2031 ($ Million)

Table 21 South America Rapid Oral Fluid Screening Device Market Value, By Product Type, 2022-2031 ($ Million)

Table 22 South America Rapid Oral Fluid Screening Device Market Value, By Form, 2022-2031 ($ Million)

Table 23 South America Rapid Oral Fluid Screening Device Market Value, By Application, 2022-2031 ($ Million)

Table 24 South America Rapid Oral Fluid Screening Device Market Value, By End User, 2022-2031 ($ Million)

Table 25 South America Rapid Oral Fluid Screening Device Market Value, By Country, 2022-2031 ($ Million)

Table 26 Europe Rapid Oral Fluid Screening Device Market Value, By Product Type, 2022-2031 ($ Million)

Table 27 Europe Rapid Oral Fluid Screening Device Market Value, By Form, 2022-2031 ($ Million)

Table 28 Europe Rapid Oral Fluid Screening Device Market Value, By Application, 2022-2031 ($ Million)

Table 29 Europe Rapid Oral Fluid Screening Device Market Value, By End User, 2022-2031 ($ Million)

Table 30 Europe Rapid Oral Fluid Screening Device Market Value, By Country, 2022-2031 ($ Million)

Table 31 Asia-Pacific Rapid Oral Fluid Screening Device Market Value, By Product Type, 2022-2031 ($ Million)

Table 32 Asia-Pacific Rapid Oral Fluid Screening Device Market Value, By Form, 2022-2031 ($ Million)

Table 33 Asia-Pacific Rapid Oral Fluid Screening Device Market Value, By Application, 2022-2031 ($ Million)

Table 34 Asia-Pacific Rapid Oral Fluid Screening Device Market Value, By End User, 2022-2031 ($ Million)

Table 35 Asia-Pacific Rapid Oral Fluid Screening Device Market Value, By Country, 2022-2031 ($ Million)

Table 36 Middle East & Africa Rapid Oral Fluid Screening Device Market Value, By Product Type, 2022-2031 ($ Million)

Table 37 Middle East & Africa Rapid Oral Fluid Screening Device Market Value, By Form, 2022-2031 ($ Million)

Table 38 Middle East & Africa Rapid Oral Fluid Screening Device Market Value, By Application, 2022-2031 ($ Million)

Table 39 Middle East & Africa Rapid Oral Fluid Screening Device Market Value, By End User, 2022-2031 ($ Million)

Table 40 OraSure Technologies, Inc : Overview

Table 41 OraSure Technologies, Inc : Product Portfolio

Table 42 OraSure Technologies, Inc : Key Developments

Table 43 Abbott Laboratories: Overview

Table 44 Abbott Laboratories: Product Portfolio

Table 45 Abbott Laboratories: Key Developments

Table 46 Guangzhou Wondfo Biotech Co., Ltd: Overview

Table 47 Guangzhou Wondfo Biotech Co., Ltd: Product Portfolio

Table 48 Guangzhou Wondfo Biotech Co., Ltd: Key Developments

Table 49 Oranoxis Inc: Overview

Table 50 Oranoxis Inc: Product Portfolio

Table 51 Oranoxis Inc: Key Developments

Table 52 Premier Biotech, Inc: Overview

Table 53 Premier Biotech, Inc: Product Portfolio

Table 54 Premier Biotech, Inc: Key Developments

Table 55 UCP Biosciences, Inc.: Overview

Table 56 UCP Biosciences, Inc.: Product Portfolio

Table 57 UCP Biosciences, Inc.: Key Developments

Table 58 SCREEN ITALIA SRL: Overview

Table 59 SCREEN ITALIA SRL: Product Portfolio

Table 60 SCREEN ITALIA SRL: Key Developments

Table 61 Securetec Detektions-Systeme AG: Overview

Table 62 Securetec Detektions-Systeme AG: Product Portfolio

Table 63 Securetec Detektions-Systeme AG: Key Developments

Table 64 MEDACX Ltd.: Overview

Table 65 MEDACX Ltd.: Product Portfolio

Table 66 MEDACX Ltd.: Key Developments

Table 67 AccuBioTech Co. Ltd: Overview

Table 68 AccuBioTech Co. Ltd: Product Portfolio

Table 69 AccuBioTech Co. Ltd: Key Developments

그림 목록 (Figures)

List of Figures

Figure 01 Global Rapid Oral Fluid Screening Device Market Share, By Product Type, 2022 & 2031 (%)

Figure 02 Global Rapid Oral Fluid Screening Device Market Share, By Form, 2022 & 2031 (%)

Figure 03 Global Rapid Oral Fluid Screening Device Market Share, By Application, 2022 & 2031 (%)

Figure 04 Global Rapid Oral Fluid Screening Device Market Share, By End User, 2022 & 2031 (%)

Figure 05 Global Rapid Oral Fluid Screening Device Market Share, By Region, 2022 & 2031 (%)

Figure 06 Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 07 Global Rapid Oral Fluid Screening Device Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 08 1- Panel Saliva Drug Test Kit: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 09 4- Panel Saliva Drug Test Kits: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 10 5- Panel Saliva Drug Test Kits: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 11 6- Panel Saliva Drug Test Kits: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 12 10- Panel Saliva Drug Test Kits: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 13 12- Panel Saliva Drug Test Kits: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 14 Global Rapid Oral Fluid Screening Device Market Y-o-Y Growth, By Form, 2022-2031 (%)

Figure 15 Cassettes: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 16 Swabs: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 17 Strips: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 18 Global Rapid Oral Fluid Screening Device Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 19 Criminal Justice Testing: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 20 Workplace Testing: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 21 Disease Testing: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 22 Global Rapid Oral Fluid Screening Device Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 23 Hospitals: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 24 Diagnostic Laboratories: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 25 Forensic Laboratories: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 26 Private Employers: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 27 Home Care Settings: Global Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 28 Global Rapid Oral Fluid Screening Device Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 29 North America Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 30 North America Rapid Oral Fluid Screening Device Market Share, By Product Type, 2022 & 2031 (%)

Figure 31 North America Rapid Oral Fluid Screening Device Market Share, By Form, 2022 & 2031 (%)

Figure 32 North America Rapid Oral Fluid Screening Device Market Share, By Application, 2022 & 2031 (%)

Figure 33 North America Rapid Oral Fluid Screening Device Market Share, By End User, 2022 & 2031 (%)

Figure 34 North America Rapid Oral Fluid Screening Device Market Share, By Country, 2022 & 2031 (%)

Figure 35 South America Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 36 South America Rapid Oral Fluid Screening Device Market Share, By Product Type, 2022 & 2031 (%)

Figure 37 South America Rapid Oral Fluid Screening Device Market Share, By Form, 2022 & 2031 (%)

Figure 38 South America Rapid Oral Fluid Screening Device Market Share, By Application, 2022 & 2031 (%)

Figure 39 South America Rapid Oral Fluid Screening Device Market Share, By End User, 2022 & 2031 (%)

Figure 40 South America Rapid Oral Fluid Screening Device Market Share, By Country, 2022 & 2031 (%)

Figure 41 Europe Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 42 Europe Rapid Oral Fluid Screening Device Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Europe Rapid Oral Fluid Screening Device Market Share, By Form, 2022 & 2031 (%)

Figure 44 Europe Rapid Oral Fluid Screening Device Market Share, By Application, 2022 & 2031 (%)

Figure 45 Europe Rapid Oral Fluid Screening Device Market Share, By End User, 2022 & 2031 (%)

Figure 46 Europe Rapid Oral Fluid Screening Device Market Share, By Country, 2022 & 2031 (%)

Figure 47 Asia-Pacific Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 48 Asia-Pacific Rapid Oral Fluid Screening Device Market Share, By Product Type, 2022 & 2031 (%)

Figure 49 Asia-Pacific Rapid Oral Fluid Screening Device Market Share, By Form, 2022 & 2031 (%)

Figure 50 Asia-Pacific Rapid Oral Fluid Screening Device Market Share, By Application, 2022 & 2031 (%)

Figure 51 Asia-Pacific Rapid Oral Fluid Screening Device Market Share, By End User, 2022 & 2031 (%)

Figure 52 Asia-Pacific Rapid Oral Fluid Screening Device Market Share, By Country, 2022 & 2031 (%)

Figure 53 Middle East & Africa Rapid Oral Fluid Screening Device Market Value, 2022-2031 ($ Million)

Figure 54 Middle East & Africa Rapid Oral Fluid Screening Device Market Share, By Product Type, 2022 & 2031 (%)

Figure 55 Middle East & Africa Rapid Oral Fluid Screening Device Market Share, By Form, 2022 & 2031 (%)

Figure 56 Middle East & Africa Rapid Oral Fluid Screening Device Market Share, By Application, 2022 & 2031 (%)

Figure 57 Middle East & Africa Rapid Oral Fluid Screening Device Market Share, By End User, 2022 & 2031 (%)

Figure 58 OraSure Technologies, Inc: Financials

Figure 59 Abbott Laboratories: Financials

Figure 60 Guangzhou Wondfo Biotech Co., Ltd: Financials

Figure 61 Oranoxis Inc: Financials

Figure 62 Premier Biotech, Inc: Financials

Figure 63 UCP Biosciences, Inc.: Financials

Figure 64 SCREEN ITALIA SRL: Financials

Figure 65 Securetec Detektions-Systeme AG: Financials

Figure 66 MEDACX Ltd.: Financials

Figure 67 AccuBioTech Co. Ltd: Financials

글로벌 신속 구강액 검사 기기 시장 – 2022-2029

Global Rapid Oral Fluid Screening Device Market - 2022-2029